Plasma filtration in sepsis: a research protocol

  • S. Livigni
  • M. Maio
  • G. Bertolini
Conference paper


Sepsis is a major cause of morbidity and mortality in intensive care units (ICUs) worldwide [1]. The mortality rate in sepsis ranges from 20% to 70%, depending on the severity of the disease, the time treatment is started, the number of affected organs and the study design [2]. It has recently been described as the tenth most frequent cause of death in North America [3]. Septic shock, the most severe complication of sepsis, is characterised by a high rate of hospital mortality: 62.8% in the GiViTI (Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva) cohort in 2004 [4], which is in line with that reported in other European series [5].


Septic Shock Severe Sepsis Systemic Inflammatory Response Syndrome Continuous Renal Replacement Therapy Current Clinical Practice 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Friedman G, Silva E, Vincent JL (1998) Has mortality of septic shock changed with time? Crit Care Med 26:2078–2086PubMedCrossRefGoogle Scholar
  2. 2.
    Wheeler AP, Bernard GR (1999) Treating patients with sepsis. N Engl J Med 340:207–214PubMedCrossRefGoogle Scholar
  3. 3.
    USA National Vital Statistics Report (2001) 49:6Google Scholar
  4. 4.
    Rossi C, Bertolini G (2005) Progetto Margherita (thesis). (Rapporto 2004) Sestante, BergamoGoogle Scholar
  5. 5.
    Alberti C, Brun-Buisson C, Burchardi H et al (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28(2):108–121PubMedCrossRefGoogle Scholar
  6. 6.
    Liano G, Pascual J (1996) Acute renal failure. Madrid Acute Renal Failure Study Group. Lancet 17:347–349Google Scholar
  7. 7.
    Rangel-Frausto MS, Pittet D, Costigan M (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117–123PubMedCrossRefGoogle Scholar
  8. 8.
    Bellomo R, Ronco C (1998) Indications and criteria for initiating renal replacement therapy in the intensive care unit. Kidney Int 53[Suppl 66]:S106–S109Google Scholar
  9. 9.
    Kellum JA, Johnson JP, Kramer D et al (1998) Diffusive vs convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 26:1995–2000PubMedCrossRefGoogle Scholar
  10. 10.
    Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348(2):138–150PubMedCrossRefGoogle Scholar
  11. 11.
    Annane D, Bellissant E, Cavaillon J-M (2005) Septic shock. Lancet 365:63–78PubMedCrossRefGoogle Scholar
  12. 12.
    Singh S, Evans TW (2006) Organ dysfunction during sepsis. Intensive Care Med 32(3):349–360PubMedCrossRefGoogle Scholar
  13. 13.
    Mira JP, Cariou A, Grall F et al (1999) Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282:561–568PubMedCrossRefGoogle Scholar
  14. 14.
    Godin PJ, Buchman TG (1996) Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 24:1107–1116PubMedCrossRefGoogle Scholar
  15. 15.
    Wheeler AP, Bernard GR (1999) Treating patients with severe sepsis. N Engl J Med 340:207–214PubMedCrossRefGoogle Scholar
  16. 16.
    Ronco C, Brendolan A, Bellomo et al (2004) The Rationale for Extracorporeal Therapies in Sepsis. Adv Sepsis 4(1):2–10Google Scholar
  17. 17.
    Bellomo R, Baldwin I, Cole L et al (1988) Preliminary experience with high volume hemofiltration in human septic shock. Kidney Int 53:182–185Google Scholar
  18. 18.
    Brendolan A, Ronco C, Ricci Z et al (2004) Coupled plasma filtration adsorption: rationale, technical development and early clinical experience sepsis, kidney and multiple organ dysfunction. Contrib Nephrol 144:376–386PubMedCrossRefGoogle Scholar
  19. 19.
    Tetta C, Gianotti L, Cavaillon JM et al (2000) Continuous plasmafiltration coupled with sorbent adsorption in a rabbit model of endotoxic shock. Crit Care Med 28:1526–1533PubMedCrossRefGoogle Scholar
  20. 20.
    Ronco C, Brendolan A, Lonnemann G et al (2002) A pilot study on coupled plasma filtration with adsorption in septic shock. Crit Care Med 30:1250–1255PubMedCrossRefGoogle Scholar
  21. 21.
    Formica M, Olivieri C, Livigni S et al (2003) Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock. Intensive Care Med 29(5):703–708PubMedGoogle Scholar
  22. 22.
    Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definition Conference. Intensive Care Med 29(4):530–538PubMedGoogle Scholar
  23. 23.
    Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644–1655PubMedCrossRefGoogle Scholar
  24. 24.
    Dellinger RP, Carlet JM, Masur H et al (2004). Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 30(4):536–555PubMedCrossRefGoogle Scholar
  25. 25.
    Vincent JL, de Mendonca A, Cantraine F et al (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working Group on “Sepsis-related Problems” of the European Society of Intensive Care Medicine. Crit Care Med 26(11):1793–180PubMedGoogle Scholar
  26. 26.
    Iapichino G, Radrizzani D, Bertolini G et al (2001), Daily classification of the level of care. A method to describe clinical course of illness, use of resources and quality of intensive care assistance. Intensive Care Med 27(1):131–136PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • S. Livigni
    • 1
  • M. Maio
    • 1
  • G. Bertolini
    • 2
  1. 1.Department of Anaesthesia and Intensive CareOspedale Torino Nord Emergenza San Giovanni BoscoTurinItaly
  2. 2.GiViTI Coordinating Centre, Laboratory of Clinical Epidemiology“Mario Negri” Institute for Pharmacological ResearchRanica-BGItaly

Personalised recommendations